Key facts
- This page summarizes John Baldoni's Form 4 filing for MiNK Therapeutics, Inc. (INKT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Sep 2023, 17:01.
John Baldoni - 01 Sep 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)
- Reporting relationship
- Director
- Issuer ticker
- INKT
- Reported as of
- 01 Sep 2023
- Net transaction value
- +$14,375
- SEC form
- 4
- Accepted by SEC
- 06 Sep 2023, 17:01:47 UTC
- Prior SEC filing
- 16 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Christine Klaskin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
John Baldoni filed Form 4 for MiNK Therapeutics, Inc. (INKT) on 06 Sep 2023.
Change
- Previous filing in this sequence was filed on 16 Jun 2023.
- Current net transaction value: +$14,375.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INKT
transaction
Common stock
Award
- Transaction value
- $14,375
- Shares
- +9,846
- Change %
- +31%
- Price
- $1.46
- Shares after
- 41,193
- Date
- 01 Sep 2023
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
Footnote F2
In Table 1 of the Form 4 filed on June 2, 2023, the amount of securities acquired and price (column 4) and amount of securities beneficially owned following reported transaction (column 5) were erroneously reported. On June 1, 2023, 7,987 RSUs were acquired at a price of $1.80 each, resulting in a total amount of securities beneficially owned following the reported transaction of 31,347 instead of 31,528 as erroneously reported.